Metabolic signatures in metabolic dysfunction-associated steatotic liver disease-related hepatocellular carcinoma.

Fan WJ, Wu YM, Liu XY, Zhang CA, Hu C, Wang BB, Ding H

Open source

DOI
10.1016/j.hbpd.2026.08.008
Published
2026 Aug 27
Container
Hepatobiliary & pancreatic diseases international : HBPD INT
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.hbpd.2026.08.008,
  title = {Metabolic signatures in metabolic dysfunction-associated steatotic liver disease-related hepatocellular carcinoma.},
  author = {Fan WJ and Wu YM and Liu XY and Zhang CA and Hu C and Wang BB and Ding H},
  year = {2026},
  journal = {Hepatobiliary \& pancreatic diseases international : HBPD INT},
  doi = {10.1016/j.hbpd.2026.08.008},
  url = {https://doi.org/10.1016/j.hbpd.2026.08.008}
}

RIS

TY  - JOUR
TI  - Metabolic signatures in metabolic dysfunction-associated steatotic liver disease-related hepatocellular carcinoma.
AU  - Fan WJ
AU  - Wu YM
AU  - Liu XY
AU  - Zhang CA
AU  - Hu C
AU  - Wang BB
AU  - Ding H
PY  - 2026
JO  - Hepatobiliary & pancreatic diseases international : HBPD INT
DO  - 10.1016/j.hbpd.2026.08.008
UR  - https://doi.org/10.1016/j.hbpd.2026.08.008
ER  - 

APA

WJ, F., YM, W., XY, L., CA, Z., C, H., BB, W., & H, D. (2026). Metabolic signatures in metabolic dysfunction-associated steatotic liver disease-related hepatocellular carcinoma.. Hepatobiliary & pancreatic diseases international : HBPD INT. https://doi.org/10.1016/j.hbpd.2026.08.008

Source records